BIOCON.NSBIOCON.NSNSE

Revenue (LTM)

$152.6B

+3.4% YoY

Net Income (LTM)

$10.1B

-0.9% YoY

Free Cash Flow

$17.2B

Revenue CAGR (5Y)

+19.4%

Marginsdeclining

FCF$17.2B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	71,431	81,840↑14.6%	111,742↑36.5%	147,557↑32.1%	152,617↑3.4%
Gross Profit	48,994	50,111↑2.3%	69,617↑38.9%	91,735↑31.8%	92,441↑0.8%
Operating Income	25,978	20,044↓22.8%	33,303↑66.1%	50,832↑52.6%	47,199↓7.1%
Net Income	7,405	6,484↓12.4%	4,627↓28.6%	10,225↑121.0%	10,133↓0.9%
EBITDA	16,522	19,564↑18.4%	26,567↑35.8%	32,711↑23.1%	31,239↓4.5%
EPS Diluted	6.19	5.42↓12.4%	3.87↓28.6%	8.54↑120.7%	8.46↓0.9%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	9,526	6,626↓30.4%	13,235↑99.7%	12,334↓6.8%	32,271↑161.6%
Total Current Assets	76,004	83,823↑10.3%	123,340↑47.1%	151,792↑23.1%	162,862↑7.3%
Total Assets	185,223	203,940↑10.1%	520,428↑155.2%	560,707↑7.7%	587,973↑4.9%
Total Current Liabilities	42,101	38,280↓9.1%	85,107↑122.3%	153,588↑80.5%	143,338↓6.7%
Total Liabilities	100,147	109,240↑9.1%	295,540↑170.5%	307,959↑4.2%	310,848↑0.9%
Total Equity	76,269	84,325↑10.6%	178,669↑111.9%	197,837↑10.7%	216,440↑9.4%
Total Debt	44,811	51,466↑14.9%	180,188↑250.1%	162,767↓9.7%	183,620↑12.8%
Net Debt	35,285	44,840↑27.1%	166,953↑272.3%	150,433↓9.9%	151,349↑0.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	11,597	11,766↑1.5%	18,525↑57.4%	29,539↑59.5%	40,612↑37.5%
Capital Expenditure	-17,463	-19,248↓10.2%	-17,263↑10.3%	-19,316↓11.9%	-23,433↓21.3%
Free Cash Flow	-5,866	-7,482↓27.5%	1,262↑116.9%	10,223↑710.1%	17,179↑68.0%
Stock-Based Comp	1,060	1,257↑18.6%	1,376↑9.5%	1,006↓26.9%	1,370↑36.2%
Net Change in Cash	723	-2,433↓436.5%	6,411↑363.5%	-3,804↓159.3%	20,043↑626.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance